HomeMaterialsEuro Manganese (ASX:EMN)

Euro Manganese spotlights Chvaletice’s strategic manganese role with US ambassador visit

Materials By Maxwell Dee 3 min read

Euro Manganese advances its Chvaletice manganese project with a high-profile US ambassador visit, underscores growing market demand and geopolitical risks, and announces key board updates alongside AGM timing extension.

  • US Ambassador visits Chvaletice project site
  • IEA report spotlights Czech manganese's global role
  • Board reshuffle with new director James Connolly
  • AGM extended to November 15, 2026
  • Project aims to diversify high-purity manganese supply chains

US Ambassador's Visit Underscores Geopolitical Importance

Euro Manganese Inc. (ASX:EMN) recently hosted U.S. Ambassador Nicholas Merrick at its Chvaletice Manganese Project in the Czech Republic, marking a significant moment in the company’s efforts to position itself as a critical supplier of high-purity manganese to North American and European markets. The ambassador toured the project site and demonstration plant, receiving briefings on the planned development and its potential to bolster resilient supply chains for battery, energy storage, technology, and defence sectors.

While the visit does not constitute an official endorsement, it highlights the growing recognition of Chvaletice as a strategically important source that could reduce reliance on dominant suppliers and mitigate geopolitical risks. Euro Manganese continues to engage with key customers and financing partners globally, aiming to deliver sustainable manganese products with earlier availability from its demonstration plant.

International Energy Agency Flags Supply Concentration Risks

The International Energy Agency’s Global Critical Minerals Outlook 2026 report casts a spotlight on the Czech Republic’s emerging role, projecting it could contribute around 5% of global high-purity manganese production capacity by 2035. The report also paints a stark picture of supply concentration, noting that China accounted for virtually all supply growth in recent years, holding a dominant 72% refining market share in 2025.

This concentration, alongside export restrictions and a 9% drop in critical mineral investment last year, elevates supply risk to an immediate economic threat. The report’s findings reinforce the strategic value of projects like Chvaletice that aim to diversify sources of battery-grade manganese, a metal increasingly important for lower-cost, high-performance battery chemistries designed to reduce nickel and cobalt dependence.

Board Changes Strengthen Strategic Capabilities

Euro Manganese announced the formal appointment of James Connolly to its board, following his receipt of an Australian Director Identification Number. Connolly brings deep experience in capital projects, operations, financing, and public company governance, expected to bolster the company’s strategic execution as it advances the project and engages with partners.

Concurrently, Dr. David Dreisinger resigned from the board but will continue to support the company as a consultant. The board expressed gratitude for Dreisinger’s technical leadership and pivotal contributions to the project’s development.

AGM Timing Extended to Align with Business Priorities

Euro Manganese secured an extension from the British Columbia Registrar of Companies to hold its 2026 annual general meeting by November 15, granting additional flexibility to align the AGM with key corporate milestones. The company has promised to update shareholders on the exact date in due course, allowing time to integrate progress on project development and financing activities.

Bottom Line?

Euro Manganese’s latest update reinforces Chvaletice’s strategic potential amid tightening manganese supply and geopolitical risks, but execution on development and financing remains critical to watch.

Questions in the middle?

  • How will Euro Manganese navigate financing and offtake agreements to progress Chvaletice?
  • What impact will China’s dominant refining position have on project timelines and pricing?
  • Can the company leverage new board expertise to accelerate commercialisation amid market uncertainties?